Quantitative Mass Spectrometry Imaging Reveals Mutation Status-Independent Lack of Imatinib in Liver Metastases of Gastrointestinal Stromal Tumors

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-47089-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated With Imatinib-Resistant Gastrointestinal Stromal Tumors

Clinical Cancer Research
Cancer ResearchOncology
2012English

Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Update on the Treatment of Gastrointestinal Stromal Tumors (GISTs): Role of Imatinib

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2013English

Phase II Trial of Imatinib in Metastatic or Unresectable Gastrointestinal Stromal Tumors,NEMROCK Experience.

Research in Oncology
2006English

Gastrointestinal Stromal Tumors

Discussion of Clinical Cases
2015English

Gastrointestinal Stromal Tumors

2017English

Gastrointestinal Stromal Tumors

Deutsche Medizinische Wochenschrift
Medicine
2003English

Fluxomics: Mass Spectrometry Versus Quantitative Imaging

Current Opinion in Plant Biology
Plant Science
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy